Comparison of airway T cell phenotypes in COPD and severe asthma: the influence of smoking Source: Eur Respir J 2005; 26: Suppl. 49, 23s Year: 2005
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation Source: Eur Respir J 2004; 23: 464-476 Year: 2004
COPD disease progression and airway inflammation: uncoupled by smoking cessation Source: Eur Respir J 2005; 26: 764-766 Year: 2005
Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers Source: Eur Respir J 2013; 41: 1058-1067 Year: 2013
Smoking effect on airways inflammation in asthma and COPD: relationship with airways reversibility and hyperresponsiveness Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Source: Eur Respir J 2007; 30: 467-471 Year: 2007
Systemic inflammation in COPD in relation to smoking status Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities Year: 2020
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Source: Eur Respir J 2005; 26: 835-845 Year: 2005
Tobacco smoking alters the relationship between airway inflammation and airway hyperresponsiveness in asthma Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012
Influence of smoking on airway function and inflammation of asthmatic subjects Source: Eur Respir J 2004; 24: Suppl. 48, 283s Year: 2004
The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and quality of life in patients with asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
The tobacco smoking influence on parodontic inflammation in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 167s Year: 2007
Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD Source: Eur Respir J 2004; 23: 685-691 Year: 2004
Effect of smoking status on bronchial b-cells in COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
COPD: causal factors other than active smoking Source: Annual Congress 2006 - PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion Year: 2006
Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD Source: Eur Respir J 2004; 24: 391-396 Year: 2004
The effect of smoking on the activity of inflammatory markers in patients with COPD Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013
The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Duration of smoking cessation and bronchial inflammation in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004
The influence of smoking on the formation of cold airway hyperresponsiveness and destructive-cytolytic profile of goblet cells in asthma patients Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018